

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | protoporphyrinogen IX metabolic process (GO:0046501) | 8.95824090 |
| 2 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 7.91106972 |
| 3 | porphyrin-containing compound biosynthetic process (GO:0006779) | 6.02394123 |
| 4 | oxygen transport (GO:0015671) | 5.81854475 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.45275709 |
| 6 | L-phenylalanine catabolic process (GO:0006559) | 5.45275709 |
| 7 | tetrapyrrole biosynthetic process (GO:0033014) | 5.34446646 |
| 8 | porphyrin-containing compound metabolic process (GO:0006778) | 5.24438315 |
| 9 | gas transport (GO:0015669) | 5.22567390 |
| 10 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.19953876 |
| 11 | L-phenylalanine metabolic process (GO:0006558) | 5.19953876 |
| 12 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.15478577 |
| 13 | negative regulation of erythrocyte differentiation (GO:0045647) | 5.15197281 |
| 14 | heme biosynthetic process (GO:0006783) | 5.12823802 |
| 15 | aromatic amino acid family catabolic process (GO:0009074) | 5.05273045 |
| 16 | cysteine metabolic process (GO:0006534) | 5.04786947 |
| 17 | very-low-density lipoprotein particle assembly (GO:0034379) | 5.03034636 |
| 18 | plasma lipoprotein particle assembly (GO:0034377) | 4.93524535 |
| 19 | kynurenine metabolic process (GO:0070189) | 4.89919083 |
| 20 | alpha-linolenic acid metabolic process (GO:0036109) | 4.77366930 |
| 21 | indole-containing compound catabolic process (GO:0042436) | 4.76161974 |
| 22 | indolalkylamine catabolic process (GO:0046218) | 4.76161974 |
| 23 | tryptophan catabolic process (GO:0006569) | 4.76161974 |
| 24 | urea cycle (GO:0000050) | 4.75184974 |
| 25 | urea metabolic process (GO:0019627) | 4.75184974 |
| 26 | hemoglobin metabolic process (GO:0020027) | 4.68045551 |
| 27 | negative regulation of fibrinolysis (GO:0051918) | 4.66876438 |
| 28 | protein-lipid complex assembly (GO:0065005) | 4.60203452 |
| 29 | heme metabolic process (GO:0042168) | 4.53313938 |
| 30 | response to methylmercury (GO:0051597) | 4.53186454 |
| 31 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.51310345 |
| 32 | protein carboxylation (GO:0018214) | 4.51310345 |
| 33 | tryptophan metabolic process (GO:0006568) | 4.47360665 |
| 34 | regulation of protein activation cascade (GO:2000257) | 4.39532027 |
| 35 | nitrogen cycle metabolic process (GO:0071941) | 4.34784928 |
| 36 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.34603960 |
| 37 | lysine catabolic process (GO:0006554) | 4.33552190 |
| 38 | lysine metabolic process (GO:0006553) | 4.33552190 |
| 39 | serine family amino acid catabolic process (GO:0009071) | 4.29451928 |
| 40 | glyoxylate metabolic process (GO:0046487) | 4.28228980 |
| 41 | complement activation, alternative pathway (GO:0006957) | 4.28045833 |
| 42 | high-density lipoprotein particle remodeling (GO:0034375) | 4.27822032 |
| 43 | bile acid biosynthetic process (GO:0006699) | 4.24400517 |
| 44 | regulation of fibrinolysis (GO:0051917) | 4.23934243 |
| 45 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 4.17795445 |
| 46 | phospholipid efflux (GO:0033700) | 4.12923551 |
| 47 | regulation of complement activation (GO:0030449) | 4.10956266 |
| 48 | regulation of triglyceride catabolic process (GO:0010896) | 4.06560447 |
| 49 | regulation of response to osmotic stress (GO:0047484) | 4.06029659 |
| 50 | amino-acid betaine metabolic process (GO:0006577) | 4.01845211 |
| 51 | sulfur amino acid catabolic process (GO:0000098) | 4.01739378 |
| 52 | intracellular estrogen receptor signaling pathway (GO:0030520) | 4.01000533 |
| 53 | homocysteine metabolic process (GO:0050667) | 3.94625775 |
| 54 | erythrocyte maturation (GO:0043249) | 3.93766363 |
| 55 | cholesterol efflux (GO:0033344) | 3.89236197 |
| 56 | negative regulation of cholesterol transport (GO:0032375) | 3.88658205 |
| 57 | negative regulation of sterol transport (GO:0032372) | 3.88658205 |
| 58 | regulation of cholesterol homeostasis (GO:2000188) | 3.86356538 |
| 59 | reverse cholesterol transport (GO:0043691) | 3.85161433 |
| 60 | glycine metabolic process (GO:0006544) | 3.84635464 |
| 61 | plasma lipoprotein particle clearance (GO:0034381) | 3.79428751 |
| 62 | plasma lipoprotein particle organization (GO:0071827) | 3.73750730 |
| 63 | bile acid metabolic process (GO:0008206) | 3.71010867 |
| 64 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.69110169 |
| 65 | triglyceride homeostasis (GO:0070328) | 3.68700652 |
| 66 | acylglycerol homeostasis (GO:0055090) | 3.68700652 |
| 67 | protein-lipid complex remodeling (GO:0034368) | 3.63913146 |
| 68 | macromolecular complex remodeling (GO:0034367) | 3.63913146 |
| 69 | plasma lipoprotein particle remodeling (GO:0034369) | 3.63913146 |
| 70 | detection of bacterium (GO:0016045) | 3.63011611 |
| 71 | protein-lipid complex subunit organization (GO:0071825) | 3.62130347 |
| 72 | regulation of cholesterol esterification (GO:0010872) | 3.58934966 |
| 73 | detection of other organism (GO:0098543) | 3.55489838 |
| 74 | aromatic amino acid family metabolic process (GO:0009072) | 3.53099996 |
| 75 | serine family amino acid metabolic process (GO:0009069) | 3.52287513 |
| 76 | phospholipid homeostasis (GO:0055091) | 3.51146157 |
| 77 | glutamate metabolic process (GO:0006536) | 3.50495058 |
| 78 | alpha-amino acid catabolic process (GO:1901606) | 3.50389790 |
| 79 | heme transport (GO:0015886) | 3.50060938 |
| 80 | positive regulation of lipid catabolic process (GO:0050996) | 3.47537745 |
| 81 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.44613097 |
| 82 | response to arsenic-containing substance (GO:0046685) | 3.43254571 |
| 83 | histone H3-K36 demethylation (GO:0070544) | 3.42988436 |
| 84 | modulation by virus of host process (GO:0019054) | 3.41130799 |
| 85 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.40105254 |
| 86 | tetrapyrrole metabolic process (GO:0033013) | 3.39275384 |
| 87 | imidazole-containing compound metabolic process (GO:0052803) | 3.38694077 |
| 88 | mannose metabolic process (GO:0006013) | 3.36688367 |
| 89 | ethanol oxidation (GO:0006069) | 3.35269703 |
| 90 | myeloid cell development (GO:0061515) | 3.34742275 |
| 91 | response to lead ion (GO:0010288) | 3.33261695 |
| 92 | tyrosine metabolic process (GO:0006570) | 3.33052483 |
| 93 | bile acid and bile salt transport (GO:0015721) | 3.32926469 |
| 94 | fibrinolysis (GO:0042730) | 3.26741849 |
| 95 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.25138381 |
| 96 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.19716210 |
| 97 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.19151106 |
| 98 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.19151106 |
| 99 | arginine metabolic process (GO:0006525) | 3.18770253 |
| 100 | cellular biogenic amine catabolic process (GO:0042402) | 3.17768809 |
| 101 | amine catabolic process (GO:0009310) | 3.17768809 |
| 102 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.17523076 |
| 103 | 2-oxoglutarate metabolic process (GO:0006103) | 3.16370048 |
| 104 | cholesterol homeostasis (GO:0042632) | 3.16112759 |
| 105 | indolalkylamine metabolic process (GO:0006586) | 3.15089282 |
| 106 | carnitine metabolic process (GO:0009437) | 3.14388834 |
| 107 | cellular amino acid catabolic process (GO:0009063) | 3.12865721 |
| 108 | sterol homeostasis (GO:0055092) | 3.12248675 |
| 109 | modulation by symbiont of host cellular process (GO:0044068) | 3.11595002 |
| 110 | erythrocyte development (GO:0048821) | 3.10900144 |
| 111 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.08431690 |
| 112 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.06940979 |
| 113 | cellular response to virus (GO:0098586) | 3.05710056 |
| 114 | cofactor catabolic process (GO:0051187) | 3.05140074 |
| 115 | cellular modified amino acid catabolic process (GO:0042219) | 3.03471756 |
| 116 | positive regulation of granulocyte differentiation (GO:0030854) | 3.00975153 |
| 117 | regulation of chromatin binding (GO:0035561) | 3.00495533 |
| 118 | regulation of histone H3-K27 methylation (GO:0061085) | 2.93365693 |
| 119 | histone H3-K9 demethylation (GO:0033169) | 2.92666416 |
| 120 | detection of external biotic stimulus (GO:0098581) | 2.90051785 |
| 121 | megakaryocyte development (GO:0035855) | 2.86813664 |
| 122 | histone H4 deacetylation (GO:0070933) | 2.84604047 |
| 123 | regulation of RNA export from nucleus (GO:0046831) | 2.84501929 |
| 124 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.81642672 |
| 125 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.81642672 |
| 126 | modulation by symbiont of host immune response (GO:0052553) | 2.81642672 |
| 127 | positive regulation by symbiont of host defense response (GO:0052509) | 2.81642672 |
| 128 | modulation by symbiont of host defense response (GO:0052031) | 2.81642672 |
| 129 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.81642672 |
| 130 | definitive hemopoiesis (GO:0060216) | 2.80072990 |
| 131 | histone lysine demethylation (GO:0070076) | 2.78776266 |
| 132 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.77863428 |
| 133 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.77671000 |
| 134 | regulation of granulocyte differentiation (GO:0030852) | 2.77626206 |
| 135 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.76101243 |
| 136 | negative regulation of cell killing (GO:0031342) | 2.76101243 |
| 137 | cellular hyperosmotic response (GO:0071474) | 2.74952586 |
| 138 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.72788270 |
| 139 | response to muramyl dipeptide (GO:0032495) | 2.72546927 |
| 140 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.71526556 |
| 141 | regulation of gamma-delta T cell activation (GO:0046643) | 2.69016077 |
| 142 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.67350918 |
| 143 | response to mercury ion (GO:0046689) | 2.64422669 |
| 144 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.62649310 |
| 145 | histone demethylation (GO:0016577) | 2.62217634 |
| 146 | response to peptidoglycan (GO:0032494) | 2.58937693 |
| 147 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.57373663 |
| 148 | phosphatidylethanolamine biosynthetic process (GO:0006646) | 2.55092828 |
| 149 | granulocyte differentiation (GO:0030851) | 2.55028602 |
| 150 | thymic T cell selection (GO:0045061) | 2.54016828 |
| 151 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.53723627 |
| 152 | embryonic process involved in female pregnancy (GO:0060136) | 2.53619218 |
| 153 | regulation of ARF GTPase activity (GO:0032312) | 2.52611568 |
| 154 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.50548879 |
| 155 | positive thymic T cell selection (GO:0045059) | 2.49573211 |
| 156 | modulation by virus of host morphology or physiology (GO:0019048) | 2.49497347 |
| 157 | regulation of ARF protein signal transduction (GO:0032012) | 2.47174807 |
| 158 | response to laminar fluid shear stress (GO:0034616) | 2.46855343 |
| 159 | regulation of necroptotic process (GO:0060544) | 2.45171359 |
| 160 | detection of biotic stimulus (GO:0009595) | 2.44996727 |
| 161 | regulation of leukocyte degranulation (GO:0043300) | 2.44112324 |
| 162 | negative regulation of granulocyte differentiation (GO:0030853) | 2.43546919 |
| 163 | negative regulation of necroptotic process (GO:0060546) | 2.41030275 |
| 164 | germinal center formation (GO:0002467) | 2.40425760 |
| 165 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.38430579 |
| 166 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.38319238 |
| 167 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.38258903 |
| 168 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.38258903 |
| 169 | regulation of erythrocyte differentiation (GO:0045646) | 2.37875291 |
| 170 | regulation of mast cell degranulation (GO:0043304) | 2.37188600 |
| 171 | negative regulation of myotube differentiation (GO:0010832) | 2.36880415 |
| 172 | platelet formation (GO:0030220) | 2.36311160 |
| 173 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.36033963 |
| 174 | leukocyte aggregation (GO:0070486) | 2.35398245 |
| 175 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.35054523 |
| 176 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.34100177 |
| 177 | mRNA stabilization (GO:0048255) | 2.33473870 |
| 178 | RNA stabilization (GO:0043489) | 2.33473870 |
| 179 | protein targeting to plasma membrane (GO:0072661) | 2.33203126 |
| 180 | Peyers patch development (GO:0048541) | 2.32734716 |
| 181 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.32734716 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.59168331 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.48067506 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.02092610 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.37627579 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.33177456 |
| 6 | GATA1_22025678_ChIP-Seq_K562_Human | 3.72757306 |
| 7 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.20491675 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.18227401 |
| 9 | GATA1_19941826_ChIP-Seq_K562_Human | 3.09342294 |
| 10 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.98846649 |
| 11 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.87876824 |
| 12 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.86297619 |
| 13 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 2.63496655 |
| 14 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 2.54505977 |
| 15 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.22257888 |
| 16 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.21214686 |
| 17 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.14761877 |
| 18 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.14710435 |
| 19 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.08620009 |
| 20 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.04635759 |
| 21 | GATA2_19941826_ChIP-Seq_K562_Human | 1.93360122 |
| 22 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.92771629 |
| 23 | MYC_22102868_ChIP-Seq_BL_Human | 1.91083246 |
| 24 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.86821456 |
| 25 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.83557720 |
| 26 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.66202178 |
| 27 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.66064985 |
| 28 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.65622099 |
| 29 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.63493853 |
| 30 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.61565329 |
| 31 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.59288501 |
| 32 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.59079902 |
| 33 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.57739898 |
| 34 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.57141866 |
| 35 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.56417950 |
| 36 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.54555549 |
| 37 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.52609194 |
| 38 | SPI1_23127762_ChIP-Seq_K562_Human | 1.49959740 |
| 39 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.44343601 |
| 40 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.41686145 |
| 41 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.41447176 |
| 42 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.40194520 |
| 43 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.37743684 |
| 44 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.36425750 |
| 45 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.36110297 |
| 46 | * VDR_21846776_ChIP-Seq_THP-1_Human | 1.34332203 |
| 47 | MAF_26560356_Chip-Seq_TH1_Human | 1.33732014 |
| 48 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.32403432 |
| 49 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.31164350 |
| 50 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.30481935 |
| 51 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.30078454 |
| 52 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.27786025 |
| 53 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.27441878 |
| 54 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.24448983 |
| 55 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.23601531 |
| 56 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.21236347 |
| 57 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.21040322 |
| 58 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20314580 |
| 59 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.18414589 |
| 60 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.18293692 |
| 61 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.17216084 |
| 62 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.16935627 |
| 63 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.16894138 |
| 64 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.16694872 |
| 65 | UTX_26944678_Chip-Seq_JUKART_Human | 1.15668986 |
| 66 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.15324944 |
| 67 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.15214660 |
| 68 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.13051173 |
| 69 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.12368749 |
| 70 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.11820424 |
| 71 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.10762968 |
| 72 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10028400 |
| 73 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.09238479 |
| 74 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.09215196 |
| 75 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.07764846 |
| 76 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.07213915 |
| 77 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.03774837 |
| 78 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.03169112 |
| 79 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02856309 |
| 80 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.01706608 |
| 81 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.01665708 |
| 82 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.01413528 |
| 83 | * NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.01039872 |
| 84 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.01014038 |
| 85 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.00517381 |
| 86 | ATF3_27146783_Chip-Seq_COLON_Human | 0.99453201 |
| 87 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.98612384 |
| 88 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.98501987 |
| 89 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.98453919 |
| 90 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.98153867 |
| 91 | * CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.98109947 |
| 92 | E2F7_22180533_ChIP-Seq_HELA_Human | 0.98089969 |
| 93 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.97049749 |
| 94 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.96898572 |
| 95 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.96861408 |
| 96 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.96848035 |
| 97 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.96349860 |
| 98 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.96062322 |
| 99 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.96003038 |
| 100 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.95079211 |
| 101 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.95012840 |
| 102 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.94978628 |
| 103 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.94907015 |
| 104 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.94417345 |
| 105 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.93836266 |
| 106 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.92399116 |
| 107 | KDM2B_26808549_Chip-Seq_K562_Human | 0.92287223 |
| 108 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.91952953 |
| 109 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.91516922 |
| 110 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90681126 |
| 111 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.89902867 |
| 112 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.88784092 |
| 113 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.88779996 |
| 114 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.87821992 |
| 115 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.87357858 |
| 116 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87094474 |
| 117 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.86953901 |
| 118 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.85608498 |
| 119 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.84488910 |
| 120 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.84445417 |
| 121 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.81539223 |
| 122 | MYB_26560356_Chip-Seq_TH1_Human | 0.80749034 |
| 123 | MAF_26560356_Chip-Seq_TH2_Human | 0.79865921 |
| 124 | P68_20966046_ChIP-Seq_HELA_Human | 0.79683766 |
| 125 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.79249712 |
| 126 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.79121680 |
| 127 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.78549914 |
| 128 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.77555211 |
| 129 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.76969170 |
| 130 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.76237363 |
| 131 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.74138961 |
| 132 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.73824803 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.19369984 |
| 2 | MP0003656_abnormal_erythrocyte_physiolo | 6.10524655 |
| 3 | MP0005360_urolithiasis | 5.45274893 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.69220830 |
| 5 | MP0005365_abnormal_bile_salt | 4.42357007 |
| 6 | MP0005083_abnormal_biliary_tract | 4.08144429 |
| 7 | MP0004147_increased_porphyrin_level | 3.52022451 |
| 8 | MP0008875_abnormal_xenobiotic_pharmacok | 3.29695706 |
| 9 | MP0008260_abnormal_autophagy | 3.29039168 |
| 10 | MP0009840_abnormal_foam_cell | 3.05965430 |
| 11 | MP0003252_abnormal_bile_duct | 2.88282780 |
| 12 | MP0010329_abnormal_lipoprotein_level | 2.83972996 |
| 13 | MP0003705_abnormal_hypodermis_morpholog | 2.71801328 |
| 14 | MP0003806_abnormal_nucleotide_metabolis | 2.66342281 |
| 15 | MP0003172_abnormal_lysosome_physiology | 2.64740348 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.32033748 |
| 17 | MP0000609_abnormal_liver_physiology | 2.22361142 |
| 18 | MP0001666_abnormal_nutrient_absorption | 1.87697593 |
| 19 | MP0001849_ear_inflammation | 1.75913426 |
| 20 | MP0004381_abnormal_hair_follicle | 1.72943026 |
| 21 | MP0002138_abnormal_hepatobiliary_system | 1.69942758 |
| 22 | MP0005332_abnormal_amino_acid | 1.69267702 |
| 23 | MP0002118_abnormal_lipid_homeostasis | 1.65064683 |
| 24 | MP0003763_abnormal_thymus_physiology | 1.61644275 |
| 25 | MP0005025_abnormal_response_to | 1.58879790 |
| 26 | MP0005319_abnormal_enzyme/_coenzyme | 1.55557533 |
| 27 | MP0002419_abnormal_innate_immunity | 1.50581011 |
| 28 | MP0005409_darkened_coat_color | 1.48103309 |
| 29 | MP0005464_abnormal_platelet_physiology | 1.47361423 |
| 30 | MP0002396_abnormal_hematopoietic_system | 1.44249404 |
| 31 | MP0003300_gastrointestinal_ulcer | 1.37166584 |
| 32 | MP0001545_abnormal_hematopoietic_system | 1.36908723 |
| 33 | MP0005397_hematopoietic_system_phenotyp | 1.36908723 |
| 34 | MP0009333_abnormal_splenocyte_physiolog | 1.35718428 |
| 35 | MP0000598_abnormal_liver_morphology | 1.34006980 |
| 36 | MP0001790_abnormal_immune_system | 1.33004436 |
| 37 | MP0005387_immune_system_phenotype | 1.33004436 |
| 38 | MP0003868_abnormal_feces_composition | 1.30552324 |
| 39 | MP0002249_abnormal_larynx_morphology | 1.29826260 |
| 40 | MP0001348_abnormal_lacrimal_gland | 1.29780717 |
| 41 | MP0003195_calcinosis | 1.26698760 |
| 42 | MP0000703_abnormal_thymus_morphology | 1.25954925 |
| 43 | MP0005451_abnormal_body_composition | 1.24499226 |
| 44 | MP0001800_abnormal_humoral_immune | 1.24386895 |
| 45 | MP0004019_abnormal_vitamin_homeostasis | 1.23510755 |
| 46 | MP0002653_abnormal_ependyma_morphology | 1.20057310 |
| 47 | MP0005636_abnormal_mineral_homeostasis | 1.18856923 |
| 48 | MP0005670_abnormal_white_adipose | 1.18594718 |
| 49 | MP0002254_reproductive_system_inflammat | 1.16481190 |
| 50 | MP0001851_eye_inflammation | 1.15442865 |
| 51 | MP0003828_pulmonary_edema | 1.13911595 |
| 52 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.11421742 |
| 53 | MP0002822_catalepsy | 1.11126437 |
| 54 | MP0003436_decreased_susceptibility_to | 1.10895460 |
| 55 | MP0003878_abnormal_ear_physiology | 1.10440921 |
| 56 | MP0005377_hearing/vestibular/ear_phenot | 1.10440921 |
| 57 | MP0010307_abnormal_tumor_latency | 1.09747029 |
| 58 | MP0009763_increased_sensitivity_to | 1.09239478 |
| 59 | MP0002420_abnormal_adaptive_immunity | 1.08121100 |
| 60 | MP0004185_abnormal_adipocyte_glucose | 1.07332360 |
| 61 | MP0003091_abnormal_cell_migration | 1.07292957 |
| 62 | MP0009764_decreased_sensitivity_to | 1.06849125 |
| 63 | MP0001819_abnormal_immune_cell | 1.06055463 |
| 64 | MP0004130_abnormal_muscle_cell | 1.05831910 |
| 65 | MP0005000_abnormal_immune_tolerance | 1.05483004 |
| 66 | MP0009643_abnormal_urine_homeostasis | 1.04710925 |
| 67 | MP0000685_abnormal_immune_system | 1.04129994 |
| 68 | MP0000716_abnormal_immune_system | 1.02772290 |
| 69 | MP0010155_abnormal_intestine_physiology | 1.01982313 |
| 70 | MP0000858_altered_metastatic_potential | 1.01260964 |
| 71 | MP0001835_abnormal_antigen_presentation | 1.00419312 |
| 72 | MP0002971_abnormal_brown_adipose | 0.96930004 |
| 73 | MP0005075_abnormal_melanosome_morpholog | 0.96815952 |
| 74 | MP0002723_abnormal_immune_serum | 0.96608888 |
| 75 | MP0003303_peritoneal_inflammation | 0.96414048 |
| 76 | MP0000678_abnormal_parathyroid_gland | 0.95617202 |
| 77 | MP0004947_skin_inflammation | 0.95554411 |
| 78 | MP0004858_abnormal_nervous_system | 0.95433517 |
| 79 | MP0002009_preneoplasia | 0.95047798 |
| 80 | MP0009785_altered_susceptibility_to | 0.93591210 |
| 81 | MP0000015_abnormal_ear_pigmentation | 0.91249636 |
| 82 | MP0002452_abnormal_antigen_presenting | 0.90991999 |
| 83 | MP0004233_abnormal_muscle_weight | 0.90976383 |
| 84 | MP0005621_abnormal_cell_physiology | 0.90106869 |
| 85 | MP0009278_abnormal_bone_marrow | 0.89834339 |
| 86 | MP0003724_increased_susceptibility_to | 0.88016810 |
| 87 | MP0000604_amyloidosis | 0.87413217 |
| 88 | MP0005076_abnormal_cell_differentiation | 0.87050263 |
| 89 | MP0005666_abnormal_adipose_tissue | 0.86991660 |
| 90 | MP0003111_abnormal_nucleus_morphology | 0.86792077 |
| 91 | MP0003566_abnormal_cell_adhesion | 0.85892784 |
| 92 | MP0008469_abnormal_protein_level | 0.85775998 |
| 93 | MP0001764_abnormal_homeostasis | 0.81282218 |
| 94 | MP0009765_abnormal_xenobiotic_induced | 0.80176690 |
| 95 | MP0005334_abnormal_fat_pad | 0.79460768 |
| 96 | MP0002796_impaired_skin_barrier | 0.78556698 |
| 97 | MP0009931_abnormal_skin_appearance | 0.78518497 |
| 98 | MP0005647_abnormal_sex_gland | 0.78307310 |
| 99 | MP0010368_abnormal_lymphatic_system | 0.78036486 |
| 100 | MP0001533_abnormal_skeleton_physiology | 0.76930178 |
| 101 | MP0003186_abnormal_redox_activity | 0.76759007 |
| 102 | MP0003453_abnormal_keratinocyte_physiol | 0.76227600 |
| 103 | MP0002998_abnormal_bone_remodeling | 0.75988544 |
| 104 | MP0004883_abnormal_blood_vessel | 0.75877066 |
| 105 | MP0009053_abnormal_anal_canal | 0.73842584 |
| 106 | MP0006036_abnormal_mitochondrial_physio | 0.71389341 |
| 107 | MP0000689_abnormal_spleen_morphology | 0.71310542 |
| 108 | MP0003183_abnormal_peptide_metabolism | 0.70462248 |
| 109 | MP0005058_abnormal_lysosome_morphology | 0.69817221 |
| 110 | MP0009672_abnormal_birth_weight | 0.68071602 |
| 111 | MP0005023_abnormal_wound_healing | 0.67853535 |
| 112 | MP0005408_hypopigmentation | 0.67587861 |
| 113 | MP0009642_abnormal_blood_homeostasis | 0.67567464 |
| 114 | MP0008995_early_reproductive_senescence | 0.67303954 |
| 115 | MP0002722_abnormal_immune_system | 0.67178282 |
| 116 | MP0005501_abnormal_skin_physiology | 0.66855301 |
| 117 | MP0004510_myositis | 0.66435028 |
| 118 | MP0002970_abnormal_white_adipose | 0.66415084 |
| 119 | MP0005248_abnormal_Harderian_gland | 0.65528487 |
| 120 | MP0000371_diluted_coat_color | 0.64844448 |
| 121 | MP0002060_abnormal_skin_morphology | 0.64691004 |
| 122 | MP0008775_abnormal_heart_ventricle | 0.64483065 |
| 123 | MP0008874_decreased_physiological_sensi | 0.63848173 |
| 124 | MP0000747_muscle_weakness | 0.63727651 |
| 125 | MP0008770_decreased_survivor_rate | 0.63668733 |
| 126 | MP0002398_abnormal_bone_marrow | 0.63027597 |
| 127 | MP0002166_altered_tumor_susceptibility | 0.61360447 |
| 128 | MP0006082_CNS_inflammation | 0.60359852 |
| 129 | MP0002136_abnormal_kidney_physiology | 0.60049069 |
| 130 | MP0005167_abnormal_blood-brain_barrier | 0.58941970 |
| 131 | MP0002086_abnormal_extraembryonic_tissu | 0.58850686 |
| 132 | MP0001756_abnormal_urination | 0.58611217 |
| 133 | MP0010352_gastrointestinal_tract_polyps | 0.58565005 |
| 134 | MP0002877_abnormal_melanocyte_morpholog | 0.57552137 |
| 135 | MP0002078_abnormal_glucose_homeostasis | 0.57466936 |
| 136 | MP0009115_abnormal_fat_cell | 0.55644527 |
| 137 | MP0001243_abnormal_dermal_layer | 0.55317645 |
| 138 | MP0001915_intracranial_hemorrhage | 0.55267845 |
| 139 | MP0002269_muscular_atrophy | 0.54106138 |
| 140 | MP0002429_abnormal_blood_cell | 0.52384181 |
| 141 | MP0008961_abnormal_basal_metabolism | 0.51302071 |
| 142 | MP0010630_abnormal_cardiac_muscle | 0.50603507 |
| 143 | MP0004808_abnormal_hematopoietic_stem | 0.50513929 |
| 144 | MP0005375_adipose_tissue_phenotype | 0.50386535 |
| 145 | MP0002132_abnormal_respiratory_system | 0.49870698 |
| 146 | MP0001845_abnormal_inflammatory_respons | 0.49726977 |
| 147 | MP0005448_abnormal_energy_balance | 0.48230458 |
| 148 | MP0001853_heart_inflammation | 0.48093802 |
| 149 | MP0002088_abnormal_embryonic_growth/wei | 0.45993023 |
| 150 | MP0004264_abnormal_extraembryonic_tissu | 0.45364389 |
| 151 | MP0008872_abnormal_physiological_respon | 0.45254867 |
| 152 | MP0002405_respiratory_system_inflammati | 0.44092625 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Poikilocytosis (HP:0004447) | 8.33953633 |
| 2 | Hypochromic microcytic anemia (HP:0004840) | 6.38622453 |
| 3 | Acanthocytosis (HP:0001927) | 6.05915411 |
| 4 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 5.81603730 |
| 5 | Reticulocytosis (HP:0001923) | 5.79839234 |
| 6 | Deep venous thrombosis (HP:0002625) | 5.64275506 |
| 7 | Cholelithiasis (HP:0001081) | 5.15334071 |
| 8 | Xanthomatosis (HP:0000991) | 4.84514373 |
| 9 | Intrahepatic cholestasis (HP:0001406) | 4.79808187 |
| 10 | Abnormal gallbladder morphology (HP:0012437) | 4.73316140 |
| 11 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.63861657 |
| 12 | Hyperbilirubinemia (HP:0002904) | 4.60941863 |
| 13 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.35959770 |
| 14 | Complement deficiency (HP:0004431) | 4.17050044 |
| 15 | Hyperlipoproteinemia (HP:0010980) | 4.00496336 |
| 16 | Prolonged partial thromboplastin time (HP:0003645) | 3.96598259 |
| 17 | Hypobetalipoproteinemia (HP:0003563) | 3.93039552 |
| 18 | Hepatocellular carcinoma (HP:0001402) | 3.67719843 |
| 19 | Hypoalphalipoproteinemia (HP:0003233) | 3.53151686 |
| 20 | Joint hemorrhage (HP:0005261) | 3.45605749 |
| 21 | Hypolipoproteinemia (HP:0010981) | 3.43136480 |
| 22 | Polycythemia (HP:0001901) | 3.43064714 |
| 23 | Abnormality of the gallbladder (HP:0005264) | 3.41290850 |
| 24 | Eczematoid dermatitis (HP:0000976) | 3.38240944 |
| 25 | Myocardial infarction (HP:0001658) | 3.36040369 |
| 26 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.33217771 |
| 27 | Abnormality of reticulocytes (HP:0004312) | 3.26277139 |
| 28 | Abnormality of the common coagulation pathway (HP:0010990) | 3.24159862 |
| 29 | Hypochromic anemia (HP:0001931) | 3.20530768 |
| 30 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.17256890 |
| 31 | Abnormality of complement system (HP:0005339) | 3.17216290 |
| 32 | Epidermoid cyst (HP:0200040) | 3.15430151 |
| 33 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.15402321 |
| 34 | Cholecystitis (HP:0001082) | 3.09010601 |
| 35 | Abnormal gallbladder physiology (HP:0012438) | 3.09010601 |
| 36 | Diaphragmatic weakness (HP:0009113) | 3.03549392 |
| 37 | Paralysis (HP:0003470) | 3.00086893 |
| 38 | Hyperammonemia (HP:0001987) | 2.99247004 |
| 39 | Hypercholesterolemia (HP:0003124) | 2.94978424 |
| 40 | Obstructive sleep apnea (HP:0002870) | 2.88223772 |
| 41 | Abnormal hemoglobin (HP:0011902) | 2.79579980 |
| 42 | Global brain atrophy (HP:0002283) | 2.72817725 |
| 43 | Microcytic anemia (HP:0001935) | 2.70453568 |
| 44 | Increased IgE level (HP:0003212) | 2.66633640 |
| 45 | Pustule (HP:0200039) | 2.66628817 |
| 46 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.65674446 |
| 47 | Hyperglycinemia (HP:0002154) | 2.65141716 |
| 48 | Ketosis (HP:0001946) | 2.64851388 |
| 49 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.64728481 |
| 50 | Cellulitis (HP:0100658) | 2.61224606 |
| 51 | Nasal polyposis (HP:0100582) | 2.60893567 |
| 52 | Abnormality of iron homeostasis (HP:0011031) | 2.59618281 |
| 53 | Abnormality of the intrinsic pathway (HP:0010989) | 2.58689524 |
| 54 | Metaphyseal cupping (HP:0003021) | 2.49621622 |
| 55 | Hemorrhage of the eye (HP:0011885) | 2.47536676 |
| 56 | Hyperglycinuria (HP:0003108) | 2.45768425 |
| 57 | Recurrent abscess formation (HP:0002722) | 2.43310762 |
| 58 | Abnormality of methionine metabolism (HP:0010901) | 2.43005392 |
| 59 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.42648691 |
| 60 | Systemic lupus erythematosus (HP:0002725) | 2.40210524 |
| 61 | Hypoglycemic coma (HP:0001325) | 2.39798177 |
| 62 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.36821881 |
| 63 | Abnormality of glycine metabolism (HP:0010895) | 2.36821881 |
| 64 | Increased serum ferritin (HP:0003281) | 2.36381324 |
| 65 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.34949120 |
| 66 | Gastrointestinal infarctions (HP:0005244) | 2.33486223 |
| 67 | Abnormality of the nasal mucosa (HP:0000433) | 2.30412188 |
| 68 | Fat malabsorption (HP:0002630) | 2.28399362 |
| 69 | Exercise-induced myalgia (HP:0003738) | 2.26249063 |
| 70 | Ileus (HP:0002595) | 2.25370252 |
| 71 | Abnormality of nucleobase metabolism (HP:0010932) | 2.25137344 |
| 72 | Colitis (HP:0002583) | 2.25073889 |
| 73 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.23990264 |
| 74 | Recurrent bacterial skin infections (HP:0005406) | 2.23562444 |
| 75 | Status epilepticus (HP:0002133) | 2.22750804 |
| 76 | Gingivitis (HP:0000230) | 2.21796446 |
| 77 | Slow saccadic eye movements (HP:0000514) | 2.21247101 |
| 78 | Gingival bleeding (HP:0000225) | 2.20919207 |
| 79 | Abnormal platelet function (HP:0011869) | 2.19397448 |
| 80 | Impaired platelet aggregation (HP:0003540) | 2.19397448 |
| 81 | Insomnia (HP:0100785) | 2.18370215 |
| 82 | Broad face (HP:0000283) | 2.17413648 |
| 83 | Increased connective tissue (HP:0009025) | 2.16948490 |
| 84 | Osteomalacia (HP:0002749) | 2.15239301 |
| 85 | Menorrhagia (HP:0000132) | 2.14569586 |
| 86 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.12984555 |
| 87 | Metabolic acidosis (HP:0001942) | 2.10757539 |
| 88 | Increased mean platelet volume (HP:0011877) | 2.06545564 |
| 89 | Spontaneous abortion (HP:0005268) | 2.05373373 |
| 90 | Abnormality of purine metabolism (HP:0004352) | 2.05341776 |
| 91 | Spontaneous hematomas (HP:0007420) | 2.03930709 |
| 92 | Cerebral aneurysm (HP:0004944) | 2.02811138 |
| 93 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.02348095 |
| 94 | Esophageal varix (HP:0002040) | 2.02202085 |
| 95 | Flat acetabular roof (HP:0003180) | 2.02086268 |
| 96 | Abnormality of the Achilles tendon (HP:0005109) | 2.01988330 |
| 97 | Gastrointestinal inflammation (HP:0004386) | 2.01830766 |
| 98 | Abnormality of macrophages (HP:0004311) | 1.99780965 |
| 99 | Purpura (HP:0000979) | 1.99673378 |
| 100 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.98878633 |
| 101 | Skin nodule (HP:0200036) | 1.98470938 |
| 102 | Meningitis (HP:0001287) | 1.97578914 |
| 103 | Nausea (HP:0002018) | 1.96286669 |
| 104 | Osteomyelitis (HP:0002754) | 1.95342905 |
| 105 | Panhypogammaglobulinemia (HP:0003139) | 1.95127729 |
| 106 | Mitral stenosis (HP:0001718) | 1.94669567 |
| 107 | Gout (HP:0001997) | 1.94087291 |
| 108 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.93706521 |
| 109 | Chronic obstructive pulmonary disease (HP:0006510) | 1.93038750 |
| 110 | Obstructive lung disease (HP:0006536) | 1.93038750 |
| 111 | Spastic diplegia (HP:0001264) | 1.93034075 |
| 112 | Hypertriglyceridemia (HP:0002155) | 1.92839477 |
| 113 | Epistaxis (HP:0000421) | 1.91843735 |
| 114 | Abnormal platelet volume (HP:0011876) | 1.91532201 |
| 115 | Autoimmune thrombocytopenia (HP:0001973) | 1.91218778 |
| 116 | Glomerulonephritis (HP:0000099) | 1.91010642 |
| 117 | Recurrent viral infections (HP:0004429) | 1.90528236 |
| 118 | Confusion (HP:0001289) | 1.90324270 |
| 119 | Decreased motor nerve conduction velocity (HP:0003431) | 1.89422574 |
| 120 | Sensorimotor neuropathy (HP:0007141) | 1.88897566 |
| 121 | Back pain (HP:0003418) | 1.86722889 |
| 122 | Inflammation of the large intestine (HP:0002037) | 1.85561875 |
| 123 | Peripheral hypomyelination (HP:0007182) | 1.85389574 |
| 124 | Rickets (HP:0002748) | 1.84612522 |
| 125 | Atelectasis (HP:0100750) | 1.84606842 |
| 126 | Generalized hyperpigmentation (HP:0007440) | 1.83818282 |
| 127 | Toxemia of pregnancy (HP:0100603) | 1.83525809 |
| 128 | Muscle fiber splitting (HP:0003555) | 1.83304959 |
| 129 | Myopathic facies (HP:0002058) | 1.82963001 |
| 130 | Recurrent fungal infections (HP:0002841) | 1.80966369 |
| 131 | Abnormality of the thoracic spine (HP:0100711) | 1.79943246 |
| 132 | Thrombophlebitis (HP:0004418) | 1.79841939 |
| 133 | Long palpebral fissure (HP:0000637) | 1.79268210 |
| 134 | Pathologic fracture (HP:0002756) | 1.78787898 |
| 135 | Axonal loss (HP:0003447) | 1.78376431 |
| 136 | Heterotopia (HP:0002282) | 1.77459132 |
| 137 | Urticaria (HP:0001025) | 1.76493590 |
| 138 | Abnormal cartilage morphology (HP:0002763) | 1.76055870 |
| 139 | Abnormality of the fingertips (HP:0001211) | 1.75388306 |
| 140 | Malnutrition (HP:0004395) | 1.74632868 |
| 141 | Prolonged bleeding time (HP:0003010) | 1.74502913 |
| 142 | Bowel incontinence (HP:0002607) | 1.73089861 |
| 143 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.70512569 |
| 144 | Increased variability in muscle fiber diameter (HP:0003557) | 1.69687430 |
| 145 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.69671525 |
| 146 | Myositis (HP:0100614) | 1.69334679 |
| 147 | Agammaglobulinemia (HP:0004432) | 1.69074477 |
| 148 | Difficulty running (HP:0009046) | 1.67870558 |
| 149 | Hypertensive crisis (HP:0100735) | 1.67131264 |
| 150 | Recurrent otitis media (HP:0000403) | 1.63954775 |
| 151 | Disproportionate tall stature (HP:0001519) | 1.63527559 |
| 152 | Long eyelashes (HP:0000527) | 1.63301552 |
| 153 | Thin bony cortex (HP:0002753) | 1.62026027 |
| 154 | Seborrheic dermatitis (HP:0001051) | 1.60017121 |
| 155 | Abnormal large intestine physiology (HP:0012700) | 1.58546418 |
| 156 | Distal lower limb amyotrophy (HP:0008944) | 1.58314689 |
| 157 | Polygenic inheritance (HP:0010982) | 1.58058114 |
| 158 | Germ cell neoplasia (HP:0100728) | 1.58053952 |
| 159 | Thoracic kyphosis (HP:0002942) | 1.57768217 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PRPF4B | 4.03195819 |
| 2 | CDK12 | 3.67345255 |
| 3 | TRIB3 | 3.36213405 |
| 4 | MAP3K10 | 3.01062223 |
| 5 | ERN1 | 2.98141890 |
| 6 | PKN2 | 2.74088617 |
| 7 | EIF2AK1 | 2.63611613 |
| 8 | SIK1 | 2.54567585 |
| 9 | SMG1 | 2.49787841 |
| 10 | STK4 | 2.38865466 |
| 11 | FGFR4 | 2.35601723 |
| 12 | RIPK4 | 2.12345966 |
| 13 | EEF2K | 2.11146663 |
| 14 | TAOK3 | 1.94212094 |
| 15 | CAMK1D | 1.88542224 |
| 16 | STK10 | 1.79564326 |
| 17 | TAOK2 | 1.78941018 |
| 18 | CDK6 | 1.73457119 |
| 19 | BCKDK | 1.69429336 |
| 20 | MAPK11 | 1.64430945 |
| 21 | TYK2 | 1.63722009 |
| 22 | MARK2 | 1.60036807 |
| 23 | MAP4K1 | 1.56421956 |
| 24 | GRK6 | 1.51057242 |
| 25 | TTN | 1.50519491 |
| 26 | RIPK1 | 1.46981047 |
| 27 | PTK6 | 1.43935965 |
| 28 | TNK2 | 1.41697270 |
| 29 | KSR2 | 1.40349372 |
| 30 | JAK2 | 1.38091220 |
| 31 | MAP3K13 | 1.36414357 |
| 32 | TGFBR2 | 1.33505883 |
| 33 | MAP3K1 | 1.30160351 |
| 34 | CDK4 | 1.29885698 |
| 35 | PIM1 | 1.28658806 |
| 36 | LATS1 | 1.25241502 |
| 37 | NEK2 | 1.25101826 |
| 38 | PRKD2 | 1.24922439 |
| 39 | BMX | 1.23125118 |
| 40 | MAP2K3 | 1.21167655 |
| 41 | CAMK1G | 1.21155218 |
| 42 | DYRK1B | 1.20666020 |
| 43 | BRD4 | 1.19910761 |
| 44 | STK3 | 1.19053381 |
| 45 | TAOK1 | 1.18782250 |
| 46 | PRKAA1 | 1.18131508 |
| 47 | ICK | 1.15074468 |
| 48 | SIK3 | 1.14738627 |
| 49 | SGK3 | 1.13708235 |
| 50 | JAK1 | 1.11363729 |
| 51 | HIPK2 | 1.08493642 |
| 52 | MTOR | 1.07024638 |
| 53 | WNK1 | 1.01249990 |
| 54 | TBK1 | 0.99941405 |
| 55 | BLK | 0.99187853 |
| 56 | IRAK4 | 0.99118643 |
| 57 | ERBB2 | 0.97807788 |
| 58 | MAP3K8 | 0.96759391 |
| 59 | MAP3K7 | 0.95945676 |
| 60 | CDK9 | 0.93634871 |
| 61 | TRPM7 | 0.92661391 |
| 62 | FGR | 0.92262107 |
| 63 | RPS6KC1 | 0.91884843 |
| 64 | RPS6KL1 | 0.91884843 |
| 65 | MAP3K6 | 0.91692519 |
| 66 | PRKAA2 | 0.91603675 |
| 67 | IRAK3 | 0.89940838 |
| 68 | BTK | 0.88207682 |
| 69 | IKBKE | 0.85592818 |
| 70 | TLK1 | 0.84672427 |
| 71 | FLT3 | 0.84404163 |
| 72 | RPS6KA2 | 0.84024308 |
| 73 | PDGFRA | 0.83927684 |
| 74 | DYRK3 | 0.82745850 |
| 75 | MAPK15 | 0.81164452 |
| 76 | MAP3K11 | 0.80245638 |
| 77 | PTK2 | 0.75285494 |
| 78 | ABL2 | 0.74535715 |
| 79 | CHUK | 0.74437313 |
| 80 | FES | 0.74221194 |
| 81 | MST1R | 0.73952890 |
| 82 | MAP3K14 | 0.71861615 |
| 83 | TYRO3 | 0.70798741 |
| 84 | SYK | 0.69836527 |
| 85 | MAPK12 | 0.69775241 |
| 86 | SIK2 | 0.69497854 |
| 87 | RPS6KA6 | 0.68236344 |
| 88 | ZAP70 | 0.67637049 |
| 89 | MAP3K2 | 0.67054434 |
| 90 | MAPKAPK3 | 0.66736186 |
| 91 | MARK3 | 0.65504987 |
| 92 | SGK223 | 0.64389564 |
| 93 | SGK494 | 0.64389564 |
| 94 | IKBKB | 0.63625879 |
| 95 | DAPK2 | 0.63175407 |
| 96 | EPHB1 | 0.62401025 |
| 97 | LRRK2 | 0.61767562 |
| 98 | YES1 | 0.61518016 |
| 99 | MAP2K4 | 0.59904330 |
| 100 | SGK2 | 0.59357905 |
| 101 | CSK | 0.56747067 |
| 102 | MELK | 0.55502508 |
| 103 | JAK3 | 0.55357983 |
| 104 | FGFR3 | 0.54615688 |
| 105 | HCK | 0.54401327 |
| 106 | RPS6KA5 | 0.54112099 |
| 107 | STK38 | 0.53893892 |
| 108 | MAP2K2 | 0.52796834 |
| 109 | CAMK4 | 0.52432551 |
| 110 | ERBB4 | 0.52287297 |
| 111 | MAP3K3 | 0.49178646 |
| 112 | CDK7 | 0.47691577 |
| 113 | ZAK | 0.47309629 |
| 114 | PDGFRB | 0.46573255 |
| 115 | PDPK1 | 0.46364976 |
| 116 | PRKD3 | 0.46198078 |
| 117 | EGFR | 0.45094381 |
| 118 | NEK9 | 0.44679359 |
| 119 | PTK2B | 0.44597976 |
| 120 | PIK3CG | 0.43343410 |
| 121 | NME2 | 0.43175430 |
| 122 | PRKACG | 0.43100510 |
| 123 | CDC7 | 0.42690049 |
| 124 | LYN | 0.41902709 |
| 125 | KSR1 | 0.41437359 |
| 126 | ALK | 0.41416130 |
| 127 | SGK1 | 0.41393691 |
| 128 | RET | 0.40247797 |
| 129 | TIE1 | 0.39634139 |
| 130 | MAP3K5 | 0.39572093 |
| 131 | RPS6KA4 | 0.39352849 |
| 132 | AURKB | 0.37621414 |
| 133 | RPS6KA1 | 0.37052426 |
| 134 | PRKCH | 0.35188307 |
| 135 | MAPK7 | 0.35137996 |
| 136 | PDK1 | 0.34671279 |
| 137 | CDC42BPA | 0.33954642 |
| 138 | PRKCZ | 0.32229173 |
| 139 | CSF1R | 0.32037550 |
| 140 | CHEK1 | 0.31333215 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.03887189 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.52489962 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.29932158 |
| 4 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 3.01820342 |
| 5 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 3.01003077 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.93643485 |
| 7 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.90960200 |
| 8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.80802894 |
| 9 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.56028843 |
| 10 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.40046394 |
| 11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.34364706 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.28915401 |
| 13 | Notch signaling pathway_Homo sapiens_hsa04330 | 2.13822656 |
| 14 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.09741650 |
| 15 | ABC transporters_Homo sapiens_hsa02010 | 1.99789171 |
| 16 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.96625448 |
| 17 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.88333456 |
| 18 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.78381480 |
| 19 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.77219653 |
| 20 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.74935307 |
| 21 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.71995405 |
| 22 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.71533660 |
| 23 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.71023854 |
| 24 | Other glycan degradation_Homo sapiens_hsa00511 | 1.66761088 |
| 25 | Bile secretion_Homo sapiens_hsa04976 | 1.63600924 |
| 26 | Endometrial cancer_Homo sapiens_hsa05213 | 1.61403227 |
| 27 | Lysine degradation_Homo sapiens_hsa00310 | 1.55731614 |
| 28 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.52614399 |
| 29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.52376266 |
| 30 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.52207577 |
| 31 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.51572129 |
| 32 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.47757564 |
| 33 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.46771132 |
| 34 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.46423759 |
| 35 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.46257916 |
| 36 | Peroxisome_Homo sapiens_hsa04146 | 1.46008277 |
| 37 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.44085260 |
| 38 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.39345989 |
| 39 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.38696298 |
| 40 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.38183432 |
| 41 | Histidine metabolism_Homo sapiens_hsa00340 | 1.37888905 |
| 42 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.30955034 |
| 43 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.26629159 |
| 44 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.24881264 |
| 45 | Sulfur relay system_Homo sapiens_hsa04122 | 1.24844434 |
| 46 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.24743938 |
| 47 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.21900990 |
| 48 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.20021599 |
| 49 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.19517446 |
| 50 | Prostate cancer_Homo sapiens_hsa05215 | 1.17571713 |
| 51 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.15463323 |
| 52 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.13463456 |
| 53 | Hepatitis B_Homo sapiens_hsa05161 | 1.13315195 |
| 54 | Thyroid cancer_Homo sapiens_hsa05216 | 1.11166458 |
| 55 | Leishmaniasis_Homo sapiens_hsa05140 | 1.11007780 |
| 56 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.09687185 |
| 57 | Retinol metabolism_Homo sapiens_hsa00830 | 1.08378989 |
| 58 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.07988443 |
| 59 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.06087473 |
| 60 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.05655598 |
| 61 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.05371482 |
| 62 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.04983484 |
| 63 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.04566727 |
| 64 | Influenza A_Homo sapiens_hsa05164 | 1.02728457 |
| 65 | Carbon metabolism_Homo sapiens_hsa01200 | 1.01901497 |
| 66 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.01563802 |
| 67 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.00116167 |
| 68 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.99056678 |
| 69 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.95955334 |
| 70 | Glioma_Homo sapiens_hsa05214 | 0.93966140 |
| 71 | Colorectal cancer_Homo sapiens_hsa05210 | 0.92668738 |
| 72 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.91973644 |
| 73 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.91116686 |
| 74 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.88028712 |
| 75 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.87036179 |
| 76 | Tuberculosis_Homo sapiens_hsa05152 | 0.86374632 |
| 77 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.85561203 |
| 78 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.85383711 |
| 79 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.85263679 |
| 80 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.84581944 |
| 81 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.84469108 |
| 82 | Insulin resistance_Homo sapiens_hsa04931 | 0.83061183 |
| 83 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.82176011 |
| 84 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.81923784 |
| 85 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.81658126 |
| 86 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.80024300 |
| 87 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.79263935 |
| 88 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.78416348 |
| 89 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.72870442 |
| 90 | HTLV-I infection_Homo sapiens_hsa05166 | 0.69920459 |
| 91 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.69201742 |
| 92 | Platelet activation_Homo sapiens_hsa04611 | 0.69191527 |
| 93 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.68898272 |
| 94 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.67801805 |
| 95 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.67618531 |
| 96 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.66385080 |
| 97 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.66366504 |
| 98 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.64039823 |
| 99 | Amoebiasis_Homo sapiens_hsa05146 | 0.63897612 |
| 100 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.62082118 |
| 101 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.61893369 |
| 102 | Endocytosis_Homo sapiens_hsa04144 | 0.61863978 |
| 103 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.61822543 |
| 104 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.61759482 |
| 105 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.59684044 |
| 106 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.58170676 |
| 107 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.56651935 |
| 108 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.56117020 |
| 109 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.53226867 |
| 110 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.52918831 |
| 111 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.52561110 |
| 112 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.52396842 |
| 113 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.51754105 |
| 114 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.51386709 |
| 115 | Adherens junction_Homo sapiens_hsa04520 | 0.51336779 |
| 116 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.48639367 |
| 117 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.48585459 |
| 118 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.48274545 |
| 119 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.48066477 |
| 120 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.47942479 |
| 121 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.46436769 |
| 122 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.45489398 |
| 123 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.44979581 |
| 124 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.43840666 |
| 125 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.42933378 |
| 126 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.41007409 |
| 127 | Bladder cancer_Homo sapiens_hsa05219 | 0.38313842 |
| 128 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.38157290 |
| 129 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.37814588 |
| 130 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.35573452 |
| 131 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.32336250 |
| 132 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.32091559 |
| 133 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.31206620 |
| 134 | Malaria_Homo sapiens_hsa05144 | 0.30752622 |
| 135 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.29414518 |
| 136 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.28329026 |
| 137 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.28282930 |
| 138 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.26209350 |
| 139 | Apoptosis_Homo sapiens_hsa04210 | 0.25303712 |
| 140 | Alcoholism_Homo sapiens_hsa05034 | 0.23707107 |
| 141 | Prion diseases_Homo sapiens_hsa05020 | 0.22932260 |
| 142 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.22902540 |
| 143 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.22257994 |
| 144 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.20111895 |
| 145 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.18198476 |
| 146 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.17491743 |
| 147 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.16314716 |
| 148 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.15614539 |
| 149 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.13144392 |
| 150 | Hepatitis C_Homo sapiens_hsa05160 | 0.13020650 |
| 151 | Metabolic pathways_Homo sapiens_hsa01100 | 0.12911607 |
| 152 | Measles_Homo sapiens_hsa05162 | 0.11639224 |
| 153 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.09876482 |
| 154 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.09055400 |
| 155 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.08155474 |

